Information Provided By: 
Fly News Breaks for January 6, 2020
SYNH
Jan 6, 2020 | 17:01 EDT
In an industry initiation note, Citi analyst Patrick Donnelly initiated coverage of Syneos Health (SYNH) with a Buy rating and $75 price target, and called the name his top pick in the CRO space. The analyst noted that Syneos shares are trading at the cheapest valuation of the CROs, and sees an attractive 2020 setup for the company, as it "will benefit from three large partnerships ramping during the year while margins should see healthy expansion as some of the base spend ahead of the partnerships was realized in 2019."
News For SYNH From the Last 2 Days
There are no results for your query SYNH
